Medical disclaimer

Lu-177 PSMA therapy for prostate cancer at Memorial Şişli Hospital, Istanbul

Composite portrait based on 6 Bookimed cases of men aged 55–85 who looked into Lu-177 PSMA therapy for prostate cancer at Memorial Şişli Hospital in Istanbul. Three of the 6 came from Ukraine. The clinic's quoted price (historical, not today's price) was $6,000–$14,000.

10 min read

Prepared by Bookimed editorial team

Medical content and care coordination

Memorial Şişli Hospital
← All patient stories

Is this your situation?

  • Men aged 55–85 with advanced prostate cancer
  • Metastases in bone or pelvic lymph nodes, or a rising PSA
  • Hormone therapy already tried (4 of 6)
  • Looking for Lu-177 therapy, a repeat course or a second opinion
  • Most wanted to start as soon as possible (4 of 6)

The situation portrait

These are men aged 55–85 with advanced prostate cancer who contacted Memorial Şişli Hospital in Istanbul about Lutetium-177 PSMA therapy. Four of 6 had already had hormone therapy, 2 of 6 chemotherapy and 2 of 6 earlier Lu-177 courses. Their situations included bone metastases, pelvic lymph node metastases and a rising PSA. Most sent scans and blood results before deciding, and 4 of 6 wanted to start as soon as possible. Some patients had one Lu-177 course with a short admission, and some planned further courses.

The situation
The men in this group had metastatic or advanced prostate cancer. Bone metastases were mentioned by 2 of 6. One patient had bone and lymph node metastases, one had pelvic lymph node metastases, and one had a metastatic disease with rising PSA. One patient had castration-resistant disease, and one no longer responded to standard treatment. One patient had advanced disease after several Lu-177 sessions. Goals were practical: 2 of 6 wanted to lower PSA and control metastases, one wanted to control aggressive disease, one wanted to continue Lu-177 sessions, and one asked about spinal radiation.
The treatment
The program centred on Lu-177 therapy. Two of 6 patients had a Lu-177 course with a short admission. One patient had multiple Lu-177 courses. One had a work-up visit followed by a Lu-177 visit, and one had a pre-treatment scan before the course. One patient took a remote second opinion, and Lu-177 was paused. Some patients planned further courses after the first.

What informed the decision

  • A professor reviewed the scans remotely (2 of 6)
  • An experienced specialist (2 of 6)
  • Low price (2 of 6)
  • Transfers included (2 of 6)
  • Quick scheduling (2 of 6)

What this evidence cannot establish

  • Composite of several real cases, not one person's story.
  • Your own plan, price and recovery depend on your medical records and the treating team.

If you have bone metastases

Bone metastases were part of the situation for 2 of 6 patients, and one more patient had bone and lymph node metastases. Two of 6 said they wanted to lower PSA and control metastases. Four of 6 sent PET/CT images, and 2 of 6 sent PSA and blood tests.

If you have already had Lu-177 courses

Two of 6 patients had earlier Lu-177 courses before contacting the clinic. One patient asked for a repeat course, and one had advanced disease after several Lu-177 sessions. One patient described a fixed 6–8 week course interval. Some patients planned further courses at the clinic.

If you want to start as soon as possible

Four of 6 patients wanted to start as soon as possible. One needed a quick decision, one accepted the first offered dates, and one had flexible dates. One patient had a fixed return flight. Quick scheduling was also named as a reason for choosing the clinic by 2 of 6 patients.

If you are worried about PSA or blood counts

A PSA rise after treatment was a doubt for 2 of 6 patients, and one patient also mentioned worse blood counts. Reports after treatment varied. PSA was falling for one patient, and some patients reported low blood counts, including platelets, white cells and haemoglobin.

Typical path, in days from the first inquiry

Care timeline, measured from the first inquiry
Day 0–4

First contact and offer

Patients asked about Lu-177 in different ways. One asked for a repeat course, one asked what the treatment involves, and one asked for the procedure, duration and price.

Day 4–74

Records and decision

Four of 6 sent PET/CT images, and 2 of 6 sent PSA and blood tests. For one patient the clinic approved the case based on records.

Day 11–164

Arrival in Istanbul

Transfers were included for 2 of 6 patients. One patient also had transfers and a hotel included.

Day 17–165

Lu-177 course

Two of 6 patients had a Lu-177 course with a short admission. One had a pre-treatment scan first, and one had a work-up visit before the Lu-177 visit.

Day 20–167

Back home

Reports varied. Some patients said it went well, one saw PSA falling, and some reported lower blood counts. One patient valued ongoing contact between courses.

Typical doubts and how they were resolved

Doubts were mostly about the disease and the treatment. A PSA rise after treatment worried 2 of 6 patients. Single patients asked about Lu-177 versus actinium, the quality and dose of Lu-177, which drug and manufacturer, and new pain. Others wondered whether a new scan or PET/CT was needed, which tests and ECG were required, and whether to stop hormone injections. Practical questions covered the length of stay, hotel and transfers, travel insurance, flight timing, and what the price includes along with the cost of later cycles. One patient was unsure which Istanbul offer to choose, and one mentioned slow clinic replies.

How the cases differed

The cases differed in disease stage and treatment history. Situations ranged from bone metastases (2 of 6) to pelvic lymph node metastases, and one patient had advanced disease after several Lu-177 sessions. Four of 6 had hormone therapy before, 2 of 6 chemotherapy, and one surgery. Programs also differed. Two of 6 had a Lu-177 course with short admission, one had multiple courses, and one took a remote second opinion while Lu-177 was paused. On timing, 4 of 6 wanted to start as soon as possible, while one had flexible dates.

Key takeaways

  • Men aged 55–85 with advanced prostate cancer, often after hormone therapy (4 of 6)
  • Four of 6 wanted to start as soon as possible
  • Scans and blood results were sent before deciding
  • The clinic's quoted price was $6,000–$14,000 (historical)
  • Reports after treatment varied, including lower blood counts for some

The clinic: Memorial Şişli Hospital

  • Two of 6 patients said a professor reviewed their scans remotely.
  • Two of 6 named an experienced specialist as a reason, and one named an experienced professor.
  • Transfers were included for 2 of 6 patients, and one had transfers and an interpreter.
  • One patient chose it as an internationally accredited hospital.
Memorial Şişli Hospital

Memorial Şişli Hospital

Istanbul, Turkey

4.6/5 · 437 Bookimed reviews (current clinic profile)

The doctor: Dr. Cuneyt Turkmen

  • Dr. Cuneyt Turkmen was the doctor named in the clinic's personal offers recorded for these cases.
Cuneyt Turkmen

Cuneyt Turkmen

Nuclear medicine physician

28 years of experience

What the Lutetium-177 PSMA therapy for prostate cancer program included

Some patients planned further courses.

Included

  • Airport and clinic transfers: VIP transfer (premium vehicle service, all transfers between airport, hotel and clinic).

Not included

  • Accommodation.

Recorded stay: 2–7 days

The clinic's quoted price: $6,000–$14,000

Historical quotation

$6,000–$14,000

Based on 6 documented cases. This is not a current clinic quotation.

Range of the clinic's personal offers recorded in these cases. The final amount paid can differ and is not shown. It is not a current price.

Included

  • Airport and clinic transfers: VIP transfer (premium vehicle service, all transfers between airport, hotel and clinic).

Not included

  • Accommodation.

Not confirmed

  • Today's price for your own plan must be confirmed in a new written quotation.

Lutetium-177 PSMA therapy for prostate cancer: risks and warning signs to discuss

General patient guidance, provided separately from the case evidence. Follow your treating team's instructions.

Possible side effects

  • Low blood cell counts have happened with this drug. If blood cell counts get very low, this can lead to bleeding problems, infections, or anemia.

    Ask the treating team how this risk applies to you and how it is managed.

  • Rarely, side effects reported in people taking this drug have been deadly. These include liver problems, heart problems, bowel problems, or stroke.

    Ask the treating team how this risk applies to you and how it is managed.

  • Constipation, diarrhea, upset stomach, throwing up, and decreased appetite are common with this drug.

    Ask the treating team how this risk applies to you and how it is managed.

  • This drug may affect being able to father a child. It is not known if this effect will go back to normal.

    Ask the treating team how this risk applies to you and how it is managed.

Recovery and aftercare

  • After getting this drug, limit close contact of less than 3 feet with others for 2 days (7 days for children and pregnant people). Do not have sex for 7 days.

    Follow the treating team's instructions for your own recovery.

  • Sleep in a separate bedroom from others for 3 days, from children for 7 days, and from pregnant people for 15 days.

    Follow the treating team's instructions for your own recovery.

  • Pass urine often. You need to empty your bladder often. Drinking lots of liquids will help.

    Follow the treating team's instructions for your own recovery.

Suitability and cautions

  • If you are 75 or older, use this drug with care. You could have more side effects.

    Discuss your own suitability with the treating specialist.

  • If you are able to get pregnant or breast-feed. This drug is not approved for use in these patients.

    Discuss your own suitability with the treating specialist.

When to contact the clinic

  • Signs of infection like fever, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, or wound that will not heal.

    Contact the treating team promptly, and seek urgent local care for severe or worsening symptoms.

  • Signs of bleeding like throwing up or coughing up blood; vomit that looks like coffee grounds; blood in the urine; black, red, or tarry stools; bleeding from the gums; abnormal vaginal bleeding; bruises without a cause or that get bigger; or bleeding you cannot stop.

    Contact the treating team promptly, and seek urgent local care for severe or worsening symptoms.

  • Signs of kidney problems like unable to pass urine, change in how much urine is passed, blood in the urine, or a big weight gain.

    Contact the treating team promptly, and seek urgent local care for severe or worsening symptoms.

  • Weakness on 1 side of the body, trouble speaking or thinking, change in balance, drooping on one side of the face, or blurred eyesight.

    Contact the treating team promptly, and seek urgent local care for severe or worsening symptoms.

  • Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing, swallowing, or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.

    Contact the treating team promptly, and seek urgent local care for severe or worsening symptoms.

Frequently asked questions

What records should I send before booking Lu-177 therapy?

Four of 6 patients sent PET/CT images, and 2 of 6 sent PSA and blood tests. Others sent a PET/CT report, spine MRI, earlier scintigraphy and MRI, a medication list or a prior treatment summary. For 2 of 6 patients, a professor reviewed the scans remotely.

How much does Lu-177 therapy cost at Memorial Şişli?

The clinic's quoted price, based on 6 personal offers, was $6,000–$14,000. This is a historical price, not today's price. One patient asked what the price includes and what a later cycle costs, so ask about both.

How long do I need to stay in Istanbul?

Two of 6 patients had a Lu-177 course with a short admission. One patient had a work-up visit and then a separate Lu-177 visit. Length of stay and the timing of post-treatment checks against the flight home were questions for single patients.

Can I have more than one Lu-177 course?

Yes, some patients did. One patient had multiple Lu-177 courses, and some planned further courses. One patient chose the clinic for a clear plan of 4–6 courses, and one described a fixed 6–8 week interval between courses.

Do I need a new scan before treatment?

This was a doubt for single patients, who asked whether a new scan or a new PET/CT was needed. One patient had a pre-treatment scan before the Lu-177 course. Ask the clinic what it needs based on your records.

Discuss your own Lutetium-177 PSMA therapy for prostate cancer plan

Get a current, itemized program for your own situation.

Confirm the scope, doctor, tests, accommodation, transfers and aftercare. Historical amounts on this page do not set today's price.

Ask the clinic for a current, itemized quotation. Published evidence does not establish package inclusions or a current price.

Sources

This composite portrait is based on 6 paid Bookimed cases for the same clinic and need. Situation facets were extracted from the case material, depersonalized and counted; the text was written from that facet table only. Identifying details appear only as ranges or general groups, and only when at least two cases share them. Patient identifiers and personal records are not published. The price is the clinic's personal offer recorded in these cases, not a current price. Safety information is general guidance from the medical sources listed, not a description of these cases.

  1. 1. Memorial Şişli Hospital – clinic profile
  2. 2. Dr. Cuneyt Turkmen – professional profile
  3. 3. mskcc.org – Lutetium Lu 177 Vipivotide Tetraxetan

Related procedures

About the editorial team

Bookimed editorial team

Prepared by

Bookimed editorial team

Medical content and care coordination

Bookimed prepares evidence summaries from anonymized care records and published medical sources. The clinic and doctor are identified separately on the page.

About this page

This page summarizes cited evidence and links to current Bookimed provider profiles. It does not replace an individual diagnosis or treatment plan. Published group results are not a guarantee of your outcome.

Clinic profiles and package availability come from the current Site catalog. Historical costs and research measurements keep their original context.

Report a correction